Blood Flow Restriction Therapy for Lower Limb Injury
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Blood Flow Restriction Therapy for lower limb injury?
Is Blood Flow Restriction Therapy generally safe for humans?
Blood Flow Restriction Therapy is generally considered safe, with most side effects being minor, such as bruising, lightheadedness, and cramping. In a survey of healthcare professionals, 89% believed it was safe for people with neurologic conditions, and no side effects requiring medical attention were reported.12678
How is Blood Flow Restriction Therapy different from other treatments for lower limb injury?
What is the purpose of this trial?
The primary objective of the study is to determine the efficacy of blood flow restriction therapy on patients with lower limb extensor injuries by measuring pre and post blood flow restriction therapy strength and muscle mass.
Research Team
Guillem Gonzales-Lomas, MD
Principal Investigator
NYU Langone
Eligibility Criteria
This trial is for adults aged 18-65 with lower limb extensor injuries who plan to undergo physical therapy. It's not suitable for those under 18 or over 65, mentally impaired individuals, people using mobility aids before injury, patients with prior similar injuries, circulation issues, severe hypertension, additional leg trauma, sickle cell anemia, venous thromboembolism or cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo blood flow restriction therapy with a pressure cuff to enhance muscle hypertrophy and rehabilitation
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Blood Flow Restriction Therapy
Blood Flow Restriction Therapy is already approved in United States, Japan, European Union for the following indications:
- Musculoskeletal injuries
- Pre-surgical strengthening
- Post-surgical rehabilitation
- Arthritis
- Tendinitis
- Non-union fractures
- IT band issues
- Muscle hypertrophy
- Muscle strengthening
- Rehabilitation after injury or surgery
- Orthopedic rehabilitation
- Muscle strengthening
- Pain relief
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor